
Electromed ELMD
$ 25.6
-0.43%
Quarterly report 2025-Q4
added 02-10-2026
Electromed Total Liabilities 2011-2026 | ELMD
Annual Total Liabilities Electromed
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.6 M | 7.69 M | 8.14 M | 7.19 M | 4.69 M | 3 M | 3.62 M | 4.74 M | 3.99 M | 4.23 M | 3.48 M | 3.07 M | 3.63 M | 5.84 M | 6.16 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.6 M | 3 M | 5.34 M |
Quarterly Total Liabilities Electromed
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.47 M | 8.87 M | 10.6 M | 8.51 M | 8.67 M | 7.43 M | 7.69 M | 6.36 M | 6.62 M | 5.84 M | 8.14 M | 6.45 M | 6.04 M | 5.99 M | 7.19 M | 5.01 M | 4.72 M | 4.86 M | 4.69 M | 4.69 M | 3.49 M | 3.53 M | 3 M | 3 M | 3.03 M | 3.33 M | 3.67 M | 3.67 M | - | - | 4.74 M | 3.75 M | 3.78 M | 3.83 M | 3.99 M | 3.99 M | 3.48 M | 3.05 M | 4.22 M | 4.22 M | 3.61 M | 3.32 M | 3.48 M | 3.48 M | 3.12 M | 3.4 M | 3.07 M | 3.07 M | 3.98 M | 3.78 M | 3.63 M | 3.63 M | 4.46 M | 5.39 M | 5.84 M | 5.84 M | 5.66 M | 6.16 M | 6.16 M | 6.16 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.6 M | 3 M | 5.01 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 13.17 | 0.46 % | $ 1.78 B | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 10.8 | 4.05 % | $ 387 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
27.2 M | $ 3.47 | 4.52 % | $ 130 M | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.12 | 3.92 % | $ 1.29 M | ||
|
Inspire Medical Systems
INSP
|
126 M | $ 56.7 | 1.0 % | $ 1.67 B | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
1.41 B | $ 61.0 | 1.5 % | $ 3.33 B | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 11.37 | 1.7 % | $ 322 M | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.61 | 0.36 % | $ 38 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.03 | - | $ 17.4 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 15.65 | 3.92 % | $ 367 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 5.4 | 12.97 % | $ 1.14 B | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 2.41 | 14.22 % | $ 6.68 M | ||
|
Globus Medical
GMED
|
730 M | $ 91.34 | 1.29 % | $ 12.4 B | ||
|
TransMedics Group
TMDX
|
595 M | $ 100.01 | -0.77 % | $ 3.4 B | ||
|
NanoVibronix
NAOV
|
7.63 M | - | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 36.8 | 0.38 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
1.66 B | $ 84.03 | -5.06 % | $ 2.92 B | ||
|
Stryker Corporation
SYK
|
25.4 B | $ 294.73 | -6.47 % | $ 113 B | ||
|
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 83.98 | 0.57 % | $ 49.1 B | ||
|
Tandem Diabetes Care
TNDM
|
726 M | $ 19.41 | -0.61 % | $ 1.32 B | ||
|
LENSAR
LNSR
|
83.7 M | $ 5.61 | 7.27 % | $ 67.1 M | ||
|
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.35 | 5.47 % | $ 54.9 M | ||
|
MiMedx Group
MDXG
|
86.1 M | $ 3.68 | 9.52 % | $ 544 M | ||
|
Myomo
MYO
|
27.2 M | $ 0.9 | 4.16 % | $ 37.7 M |